XML 39 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
Fair Value of Financial Instruments

The Company has established and documented processes for determining fair values. Fair value is based upon quoted market prices, where available. If listed prices or quotes are not available, then fair value is based upon internally developed models that primarily use inputs that are market-based or independently-sourced market parameters, including interest rate yield curves.

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of valuation hierarchy are defined as follows:

Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
 
Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy.

a.
Investment Securities, Available for Sale – The Company determines the fair value of the investment securities in our portfolio, except the CMBS held in securitization trusts, using a third-party pricing service or quoted prices provided by dealers who make markets in similar financial instruments. Dealer valuations typically incorporate common market pricing methods, including a spread measurement to the Treasury curve or interest rate swap curve as well as underlying characteristics of the particular security including coupon, periodic and life caps, collateral type, rate reset period and seasoning or age of the security. If quoted prices for a security are not reasonably available from a dealer, the security will be classified as a Level 3 security and, as a result, management will determine fair value by modeling the security based on its specific characteristics and available market information. Management reviews all prices used in determining fair value to ensure they represent current market conditions. This review includes surveying similar market transactions, comparisons to interest pricing models as well as offerings of like securities by dealers. The Company's investment securities, except the CMBS held in securitization trusts, are valued based upon readily observable market parameters and are classified as Level 2 fair values.

The Company’s CMBS held in securitization trusts at December 31, 2018 were comprised of first loss POs and certain IOs for which there were not substantially similar securities that traded frequently. The Company classified these securities as Level 3 fair values. Fair value of the Company’s CMBS investments held in securitization trusts was based on an internal valuation model that considered expected cash flows from the underlying loans and yields required by market participants. The significant unobservable inputs used in the measurement of these investments were projected losses of certain identified loans within the pool of loans and a discount rate. The discount rate used in determining fair value incorporated default rate, loss severity and current market interest rates. The discount rate ranged from 4.5% to 9.5% as of December 31, 2018. Significant increases or decreases in these inputs would have resulted in a significantly lower or higher fair value measurement.

b.
Multi-Family Loans Held in Securitization Trusts – Multi-family loans held in securitization trusts are carried at fair value and classified as Level 3 fair values. In accordance with the practical expedient in ASC 810, the Company determines the fair value of multi-family loans held in securitization trusts based on the fair value of its Multi-Family CDOs and its retained interests from these securitizations (eliminated in consolidation in accordance with GAAP), as the fair value of these instruments is more observable.

c.
Derivative Instruments – The Company’s derivative instruments are classified as Level 2 fair values and are measured using valuations reported by the clearing house, CME Clearing, through which these instruments were cleared. The derivatives are presented net of variation margin payments pledged or received.

d.
Multi-Family CDOs – Multi-Family CDOs are recorded at fair value and classified as Level 3 fair values. The fair value of Multi-Family CDOs is determined using a third party pricing service or are based on quoted prices provided by dealers who make markets in similar financial instruments. The dealers will consider contractual cash payments and yields expected by market participants. Dealers also incorporate common market pricing methods, including a spread measurement to the Treasury curve or interest rate swap curve as well as underlying characteristics of the particular security including coupon, periodic and life caps, collateral type, rate reset period and seasoning or age of the security.

e.
Investments in Unconsolidated Entities – Fair value for investments in unconsolidated entities is determined based on a valuation model using assumptions for the timing and amount of expected future cash flow for income and realization events for the underlying assets in the unconsolidated entities and a discount rate. This fair value measurement is generally based on unobservable inputs and, as such, is classified as Level 3 in the fair value hierarchy.

f.
Residential Mortgage Loans – Certain of the Company’s acquired distressed and other residential mortgage loans are recorded at fair value and classified as Level 3 in the fair value hierarchy. The fair value for distressed and other residential mortgage loans is determined using valuations obtained from a third party that specializes in providing valuations of residential mortgage loans. The valuation approach depends on whether the residential mortgage loan is considered performing, re-performing or non-performing at the date the valuation is performed.

For performing and re-performing loans, estimates of fair value are derived using a discounted cash flow model, where estimates of cash flows are determined from scheduled payments for each loan, adjusted using forecast prepayment rates, default rates and rates for loss upon default. For non-performing loans, asset liquidation cash flows are derived based on the estimated time to liquidate the loan, expected liquidation costs and home price appreciation. The discount rate used in determining fair value for distressed and other residential mortgage loans ranges from 3.9% to 12.8%.

Any changes to the valuation methodology are reviewed by management to ensure the changes are appropriate. As markets and products develop and the pricing for certain products becomes more transparent, the Company continues to refine its valuation methodologies. The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of each reporting date, which may include periods of market dislocation, during which time price transparency may be reduced. This condition could cause the Company’s financial instruments to be reclassified from Level 2 to Level 3 in future periods.

    
The following table presents the Company’s financial instruments measured at fair value on a recurring basis as of September 30, 2019 and December 31, 2018, respectively, on the Company’s condensed consolidated balance sheets (dollar amounts in thousands):
 
Measured at Fair Value on a Recurring Basis at
 
September 30, 2019
 
December 31, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets carried at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment securities available for sale:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency RMBS
$

 
$
955,838

 
$

 
$
955,838

 
$

 
$
1,037,730

 
$

 
$
1,037,730

Non-Agency RMBS

 
621,528

 

 
621,528

 

 
214,037

 

 
214,037

CMBS

 
278,398

 

 
278,398

 

 
207,785

 
52,700

 
260,485

ABS

 
48,254

 

 
48,254

 

 

 

 

Multi-family loans held in securitization trusts

 

 
15,863,264

 
15,863,264

 

 

 
11,679,847

 
11,679,847

Distressed and other residential mortgage loans, at fair value

 

 
1,116,128

 
1,116,128

 

 

 
737,523

 
737,523

Derivative assets:
 
 
 
 
 
 


 
 
 
 
 
 
 


Interest rate swaps (1)

 
20,673

 

 
20,673

 

 
10,263

 

 
10,263

Investments in unconsolidated entities

 

 
76,249

 
76,249

 

 

 
32,994

 
32,994

Total
$

 
$
1,924,691

 
$
17,055,641

 
$
18,980,332

 
$

 
$
1,469,815

 
$
12,503,064

 
$
13,972,879

Liabilities carried at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Multi-family collateralized debt obligations
$

 
$

 
$
14,978,199

 
$
14,978,199

 
$

 
$

 
$
11,022,248

 
$
11,022,248

Total
$

 
$

 
$
14,978,199

 
$
14,978,199

 
$

 
$

 
$
11,022,248

 
$
11,022,248


    
(1) 
All of the Company's interest rate swaps outstanding are cleared through a central clearing house. The Company exchanges variation margin for swaps based upon daily changes in fair value. Includes derivative liabilities of $40.4 million netted against a variation margin of $61.1 million at September 30, 2019. Includes derivative assets of $1.8 million and variation margin of $8.5 million at December 31, 2018.
The following tables detail changes in valuation for the Level 3 assets for the nine months ended September 30, 2019 and 2018, respectively (amounts in thousands):

Level 3 Assets:
 
Nine Months Ended September 30, 2019
 
Multi-family loans held in securitization trusts
 
Distressed and other residential mortgage loans
 
Investments in unconsolidated entities
 
CMBS held in securitization trusts
 
Total
Balance at beginning of period
$
11,679,847

 
$
737,523

 
$
32,994

 
$
52,700

 
$
12,503,064

Total gains/(losses) (realized/unrealized)
 
 
 
 
 
 
 
 
 
Included in earnings
760,132

 
44,913

 
7,169

 
17,734

 
829,948

Included in other comprehensive income (loss)

 

 

 
(13,665
)
 
(13,665
)
Transfers in

 

 

 

 

Transfers out

 
(437
)
 

 

 
(437
)
Contributions

 

 
50,000

 

 
50,000

Paydowns/Distributions
(368,811
)
 
(106,113
)
 
(13,914
)
 

 
(488,838
)
Charge-off
(3,510
)
 

 

 

 
(3,510
)
Sales

 
(19,814
)
 

 
(56,769
)
 
(76,583
)
Purchases (1)
3,795,606

 
460,056

 

 

 
4,255,662

Balance at the end of period
$
15,863,264

 
$
1,116,128

 
$
76,249

 
$

 
$
17,055,641


(1) 
During the nine months ended September 30, 2019, the Company purchased first loss PO securities, and certain IOs and senior or mezzanine CMBS securities issued from securitizations that it determined to consolidate and included in the Consolidated K-Series. As a result, the Company consolidated assets of these securitizations in the amount of $3.8 billion during the nine months ended September 30, 2019 (see Notes 2 and 6).

 
Nine Months Ended September 30, 2018
 
Multi-family loans held in securitization trusts
 
Distressed and other residential mortgage loans
 
Investments in unconsolidated entities
 
CMBS held in securitization trusts
 
Total
Balance at beginning of period
$
9,657,421

 
$
87,153

 
$
42,823

 
$
47,922

 
$
9,835,319

Total (losses)/gains (realized/unrealized)
 
 
 
 
 
 
 
 
 
Included in earnings
(289,797
)
 
(1,361
)
 
7,930

 
2,928

 
(280,300
)
Included in other comprehensive income (loss)

 

 

 
901

 
901

Transfers in

 

 

 

 

Transfers out

 

 

 

 

Contributions

 

 

 

 

Paydowns/Distributions
(101,953
)
 
(15,456
)
 
(15,692
)
 

 
(133,101
)
Sales

 
(7,105
)
 

 

 
(7,105
)
Purchases (1)
805,163

 
118,679

 

 

 
923,842

Balance at the end of period
$
10,070,834

 
$
181,910

 
$
35,061

 
$
51,751

 
$
10,339,556


(1) 
During the nine months ended September 30, 2018, the Company purchased first loss PO securities and certain IOs and mezzanine CMBS securities issued from securitizations that it determined to consolidate and included in the Consolidated K-Series. As a result, the Company consolidated assets of these securitizations in the amount of $0.8 billion during the nine months ended September 30, 2018 (see Notes 2 and 6).

The following table details changes in valuation for the Level 3 liabilities (Multi-family CDOs) for the nine months ended September 30, 2019 and 2018, respectively (amounts in thousands):

Level 3 Liabilities:
 
Nine Months Ended September 30,
 
2019
 
2018
Balance at beginning of period
$
11,022,248

 
$
9,189,459

Total losses (gains) (realized/unrealized)
 
 
 
Included in earnings
694,043

 
(350,674
)
Purchases (1)
3,633,525

 
767,477

Paydowns
(368,107
)
 
(101,949
)
Charge-off
(3,510
)
 

Balance at the end of period
$
14,978,199

 
$
9,504,313



(1) 
During the nine months ended September 30, 2019 and 2018, the Company purchased PO securities and certain IOs and senior or mezzanine CMBS securities issued from securitizations that it determined to consolidate and included in the Consolidated K-Series. As a result, the Company consolidated liabilities of these securitizations in the amount of $3.6 billion and $0.8 billion during the nine months ended September 30, 2019 and 2018, respectively (see Notes 2 and 6).

The following table details the changes in unrealized gains (losses) included in earnings for the three and nine months ended September 30, 2019 and 2018 for our Level 3 assets and liabilities held as of September 30, 2019 and 2018, respectively (dollar amounts in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
Assets
 
 
 
 
 
 
 
Multi-family loans held in securitization trusts (1)
$
197,837

 
$
(33,153
)
 
$
802,625

 
$
(252,899
)
Investments in unconsolidated entities (2)
449

 
4,092

 
1,295

 
5,359

Distressed and other residential mortgage loans, at fair value (1)
17,413

 
(629
)
 
37,079

 
(754
)
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
Multi-family debt held in securitization trusts (1)
(190,207
)
 
45,456

 
(780,378
)
 
284,766



(1) 
Presented in unrealized gains (losses), net on the Company's condensed consolidated statements of operations.
(2) 
Presented in other income on the Company's condensed consolidated statements of operations.

The following table presents assets measured at fair value on a non-recurring basis as of September 30, 2019 and December 31, 2018, respectively, on the Company's condensed consolidated balance sheets (dollar amounts in thousands):
 
Assets Measured at Fair Value on a Non-Recurring Basis at
 
September 30, 2019
 
December 31, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Residential mortgage loans held in securitization trusts – impaired loans, net

 

 
$
5,350

 
$
5,350

 

 

 
$
5,921

 
$
5,921



The following table presents gains (losses) incurred for assets measured at fair value on a non-recurring basis for the three and nine months ended September 30, 2019 and 2018, respectively, on the Company’s condensed consolidated statements of operations (dollar amounts in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
Residential mortgage loans held in securitization trusts – impaired loans, net
$
13

 
$
(17
)
 
$
(24
)
 
$
93



Residential Mortgage Loans Held in Securitization Trusts – Impaired Loans, net – Impaired residential mortgage loans held in securitization trusts are recorded at amortized cost less specific loan loss reserves. Impaired loan value is based on management’s estimate of the net realizable value taking into consideration local market conditions of the property, updated appraisal values of the property and estimated expenses required to remediate the impaired loan.

The following table presents the carrying value and estimated fair value of the Company’s financial instruments at September 30, 2019 and December 31, 2018, respectively (dollar amounts in thousands):
 
 
 
September 30, 2019
 
December 31, 2018
 
Fair Value
Hierarchy Level
 
Carrying
Value
 
Estimated
Fair Value
 
Carrying
Value
 
Estimated
Fair Value
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
Level 1
 
$
65,906

 
$
65,906

 
$
103,724

 
$
103,724

Investment securities, available for sale
Level 2 or 3
 
1,904,018

 
1,904,018

 
1,512,252

 
1,512,252

Distressed and other residential mortgage loans, at fair value
Level 3
 
1,116,128

 
1,116,128

 
737,523

 
737,523

Distressed and other residential mortgage loans, net
Level 3
 
210,466

 
213,398

 
285,261

 
289,376

Investments in unconsolidated entities
Level 3
 
168,933

 
170,150

 
73,466

 
73,833

Preferred equity and mezzanine loan investments
Level 3
 
178,997

 
181,626

 
165,555

 
167,739

Multi-family loans held in securitization trusts
Level 3
 
15,863,264

 
15,863,264

 
11,679,847

 
11,679,847

Derivative assets
Level 2
 
20,673

 
20,673

 
10,263

 
10,263

Mortgage loans held for sale, net (1)
Level 3
 
2,437

 
2,525

 
3,414

 
3,584

Mortgage loans held for investment (1)
Level 3
 

 

 
1,580

 
1,580

Financial Liabilities:
 
 
 
 
 
 
 
 
 
Repurchase agreements
Level 2
 
2,559,880

 
2,559,880

 
2,131,505

 
2,131,505

Residential collateralized debt obligations
Level 3
 
42,119

 
40,534

 
53,040

 
50,031

Multi-family collateralized debt obligations
Level 3
 
14,978,199

 
14,978,199

 
11,022,248

 
11,022,248

Securitized debt
Level 3
 

 

 
42,335

 
45,030

Subordinated debentures
Level 3
 
45,000

 
41,273

 
45,000

 
44,897

Convertible notes
Level 2
 
132,395

 
140,557

 
130,762

 
135,689



(1) 
Included in receivables and other assets in the accompanying condensed consolidated balance sheets.

In addition to the methodology to determine the fair value of the Company’s financial assets and liabilities reported at fair value on a recurring basis and non-recurring basis, as previously described, the following methods and assumptions were used by the Company in arriving at the fair value of the Company’s other financial instruments in the table immediately above:

a.
Cash and cash equivalents – Estimated fair value approximates the carrying value of such assets.

b.
Distressed and other residential mortgage loans, net and Mortgage loans held for sale, net – The fair value is determined using valuations obtained from a third party that specializes in providing valuations of residential mortgage loans. For performing and re-performing loans, estimates of fair value are derived using a discounted cash flow model, where estimates of cash flows are determined from scheduled payments for each loan, adjusted using forecast prepayment rates, default rates and rates for loss upon default. For non-performing loans, asset liquidation cash flows are derived based on the estimated time to liquidate the loan, expected liquidation costs and home price appreciation.

c.
Preferred equity and mezzanine loan investments – Estimated fair value is determined by both market comparable pricing and discounted cash flows. The discounted cash flows are based on the underlying contractual cash flows and estimated changes in market yields. The fair value also reflects consideration of changes in credit risk since the origination or time of initial investment.

d.
Repurchase agreements – The fair value of these repurchase agreements approximates cost as they are short term in nature.

e.
Residential collateralized debt obligations – The fair value of these CDOs is based on discounted cash flows as well as market pricing on comparable obligations.

f.
Securitized debt – The fair value of securitized debt is based on discounted cash flows using management’s estimate for market yields.

g.
Subordinated debentures – The fair value of these subordinated debentures is based on discounted cash flows using management’s estimate for market yields.

h.
Convertible notes – The fair value is based on quoted prices provided by dealers who make markets in similar financial instruments.